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“I wouldn’t be here today if it were not for the NHS” 
was Professor Steven Hawking’s response1 to an 
American newspaper that used him as an example to 
highlight the deficiencies of the UK National Health 
Service (NHS) by writing, “People such as scientist 
Stephen Hawking wouldn’t have a chance in the UK, 
where the National Health Service would say the life of 
this brilliant man, because of his physical handicaps, is 
essentially worthless”.2
Since the NHS is celebrating its 70th anniversary, 
it is timely to take stock of what has been achieved 
thus far in terms of population health. Over the 
past 150 years or so, people in the UK have seen 
tremendous increases in the number of years they 
could expect to live. In 1871, the average newborn 
girl would live about 45 years (vs 41 years for boys); 
by 2016, this life expectancy had almost doubled to 
83 years (vs 79 years for boys).3 Much of this increase 
in life expectancy was, at least initially, due to 
improvements in public health, such as the provision 
of clean drinking water, safe sewage disposal, and 
improved food safety. Advances in medicine and 
health care played an increasingly important part 
too, raising—at the time of the creation of the NHS in 
1948— hopes that all diseases could be cured.4 Indeed, 
as new interventions became progressively available 
to treat common conditions, there were remarkable 
reductions in death rates from conditions that were 
potentially amenable to health care,5 including heart 
disease6 and treatable cancers.7
However, as people live longer, an increasing 
number are living with often multiple, long-term 
conditions. As the UK analysis of the Global Burden of 
Disease Study 2016 by Nicholas Steel and colleagues8 
in The Lancet shows, the number of years lived with 
disability now surpasses the number of years of life 
lost. The study provides important insights into the 
patterns of disease burden across the devolved nations 
of the UK, across English local authorities, and over 
time. Some findings are perhaps not surprising; the 
mortality burden has remained highest in Scotland 
from 1990 to 2016,9 and in the most deprived local 
authorities compared with the least deprived, by 
over two times. However, Steel and colleagues add 
granularity by providing detail down to the local 
level that, as the authors note, “can support various 
local, regional, and national actions”, including the 
development of integrated care systems.
Here is where the challenge lies. Over half of the 
mortality burden is attributable to behavioural risk 
factors, such as tobacco use, poor diet, alcohol and drug 
use, and low physical activity, and to environmental 
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Under the 2015 Addis Ababa Action Agenda on 
financing for development, countries pledged to 
reach the Sustainable Development Goals (SDGs) 
primarily using domestic resources.1 The Global 
Financing Facility for Every Woman and Every Child 
(GFF), launched at the Addis Ababa summit, advances 
this agenda by working with ministries of finance and 
health to link development assistance to increased 
domestic health investment.
On Nov 6, 2018, we are co-hosting GFF’s first 
replenishment event in Oslo, Norway, to expand GFF’s 
crucial work to improve maternal, child, and adolescent 
health and nutrition outcomes. We will also be co-
hosting a linked conference a day earlier, on Domestic 
Resource Use and Mobilisation for health (DRUM). 
Many countries today are testing health financing 
policies that hold promise for generating the funds 
needed to achieve the health-related SDGs (SDG3+) 
Financing the SDGs: mobilising and using domestic resources 
for health and human capital
factors, such as air pollution. The authors highlight the 
key role that health services should have by prioritising 
primary prevention. Indeed, one of the core functions 
of the proposed integrated care systems in England is 
to place greater emphasis on population health and 
preventing ill health.10 Yet, as Steel and colleagues 
also acknowledge, much of the need for action lies 
outside the immediate control of the health service. 
Thus, an effective strategy needs to consider the wider 
context within which people live and efforts should 
go beyond targeting the individual, taking greater 
account of the organisational and system levels in 
particular. Strategies also need to go beyond the health-
care context to fully consider the broader influences 
that affect people’s lives. As Rutter and colleagues11 
have highlighted, the achievement of meaningful 
effects on complex multi-causal problems (eg, obesity) 
requires a multifaceted approach that cannot solely 
rely on a series of single, unlinked interventions that 
require the individual to act (for example, making 
healthy choices on the basis of traffic light labelling 
of food or taking up exercise on prescription). Such 
interventions tend to have low reach and widen 
health inequalities. There is a need for a wider policy 
framework that is mindful of the potential tensions 
and unintended consequences of policies that are 
not consistent, recognises the influence of powerful 
corporate actors in undermining public health policies 
that seek to promote health,12 and creates a policy 
environment that provides the means for those who 
are asked to implement change to acquire the capacity 
and competence to do so.
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